K. Stalin´ski et al. / Journal of Organometallic Chemistry 691 (2006) 2394–2402
2397
Major diastereoisomer 9a: 1H NMR (CDCl3) ppm:
8.70–7.22 (9H, m, Harom.), 4.52 (1H, t, J = 9.3
Hz, –OCH2CHN–), 4.37 (1H, dd, J = 8.8 Hz, J = 7.2 Hz,
–OCH2CHN–), 4.16 (1H, ddd, J = 9.9 Hz, J = 7.1 Hz,
J = 4.4 Hz, –OCH2CHN–), 1.52–1.47 (1H, m, –CHMe2),
1.49 [9H, s, 3J(1H–117/119Sn) = 102.6/107.3 Hz, –SntBu],
0.69 (3H, d, J = 6.8 Hz, –CHMe2), 0.26 (3H, d, J =
6.8 Hz, –CHMe2). 13C NMR (CDCl3) ppm: 170.0
[J(13C–117/119Sn) = 8.9 Hz, C10], 147.1 [J(13C–117/119Sn) =
638/667 Hz, C1], 144.0 [J(13C–117/119Sn) = 552/578 Hz,
623/652 Hz, C1], 142.4 [J(13C–117/119Sn) = 523/547 Hz,
Cphenyl], 140.5 134.6
[J(13C–117/119Sn) = 36.3 Hz],
[J(13C–117/119Sn) = 41.4 Hz], 132.7 [J(13C–117/119Sn) =
54.7 Hz], 129.7, 129.6 128.3 [J(13C–117/119Sn) = 19.3 Hz],
128.1, 127.0 [J(13C–117/119Sn) = 37.0 Hz], 70.8 (C30), 70.4
[J(13C–117/119Sn) = 10.1 Hz, C40], 37.5 [J(13C–117/119Sn) =
579/606 Hz, –SnC(CH3)3], 31.8 [–SnC(CH3)3], 30.1 (C50),
19.5 and 14.6 (C60). 117Sn NMR (CDCl3) ppm: ꢀ133.2.
15N NMR (CDCl3) ppm: ꢀ179.7 [J(15N–117/119Sn) =
112.6 Hz].
C
phenyl],
[J(13C–117/119Sn) = 43.0 Hz], 132.9 [J(13C–117/119Sn) =
55.7 Hz], 130.2 129.5
[J(13C–117/119Sn) = 29.1 Hz],
[J(13C–117/119Sn) = 13.6 Hz], 128.7 [J(13C–117/119Sn) =
13.5 Hz], 128.3 127.0
[J(13C–117/119Sn) = 56.0 Hz],
139.3
[J(13C–117/119Sn) = 35.5 Hz],
135.2
Minor diastereoisomer 10b: 1H NMR (CDCl3) ppm:
8.79–7.20 (9H, m,
Harom.), 4.54–4.50 (1H, m,
–OCH2CHN–), 4.37 (1H, t, J = 8.7 Hz, –OCH2CHN–),
3.55–3.49 (1H, m, –OCH2CHN–), 2.13–2.06 (1H, m,
3
–CHMe2), 1.50 [9H, s, J(1H–117/119Sn) = 102.1/106.7 Hz,
[J(13C–117/119Sn) = 39.0 Hz], 70.7 (C30), 70.6 [J(13C–
117/119Sn) = 10.3 Hz, C40], 37.9 [J(13C–117/119Sn) = 600/
628 Hz, –SnC(CH3)3], 31.6 [–SnC(CH3)3], 30.4 (C50), 19.6
and 14.9 (C60). 117Sn NMR (CDCl3) ppm: ꢀ149.9.
–SntBu], 0.79 (6H, 2 · d, J = 6.7 Hz, –CHMe2). 13C
NMR (CDCl3) ppm: 170.1 (C10), 147.5, 143.2, 139.7,
134.8 132.6, 130.4, 129.7, 128.4, 128.2, 126.7, 71.1 (C30),
69.3 (C40), 35.7 [–SnC(CH3)3], 31.4 [–SnC(CH3)3], 29.8
(C50), 20.1 and 15.5 (C60). 117Sn NMR (CDCl3) ppm:
ꢀ117.6.
Minor diastereoisomer 9b: 1H NMR (CDCl3) ppm: 8.70–
7.22 (9H, m, Harom.), 4.41–4.37 (1H, m, –OCH2CHN–),
4.32 (1H, t, J = 8.6 Hz, –OCH2CHN–), 3.65–3.59 (1H,
m, –OCH2CHN–), 2.15–2.07 (1H, m, –CHMe2), 1.47
[9H, s, 3J(1H–117/119Sn) = 101.0/105.6 Hz, –SntBu], 0.79
(6H, 2 · d, J = 6.8 Hz, –CHMe2). 13C NMR (CDCl3)
ppm: 170.1 [J(13C–117/119Sn) = 9.9 Hz, C10], 146.0
2.2.2.3. (R)-2-[(R,S)(S,R)-(2-bromo-tert-butyl-methyl-stan-
nyl)-phenyl]-4-isopropyl-4,5-dihydro-oxazole (11). Mixture
of diastereoisomers 10/1, white crystals, m.p. 85–88 ꢁC,
98%. [a]D = + 80.7 (CHCl3, c = 1). IR cmꢀ1 (film): 3057,
2961, 2925, 2874, 2850, 1634, 1466, 1380, 1262, 1095,
1046, 953, 729. MS (EI) m/z: 444 (M+ ꢀ Me, 1), 402
(100), 380 (22), 358 (7), 316 (27), 222 (19). Anal. Calcd.
for C27H26Br1N1O1Sn1: C, 44.49; H, 5.71; N, 3.05; Br,
17.41. Found: C, 44.53; H, 5.72; N, 3.11; Br, 17.56%.
Major diastereoisomer 11a: 1H NMR (CDCl3) ppm:
8.60–8.45 (1H, m, Harom.), 7.83–7.77 (1H, m, Harom.),
7.64 (1H, dt, J = 7.4 Hz, J = 1.3 Hz, Harom.), 7.46 (1H,
dt, J = 7.6 Hz, J = 1.3 Hz, Harom.), 4.59 (1H, dd, J =
10.0 Hz, J = 9.0 Hz, –OCH2CHN–), 4.50 (1H, dd,
J = 8.9 Hz, J = 7.0 Hz, –OCH2CHN–), 4.28 (ddd, J =
10.2 Hz, J = 6.4 Hz, J = 3.2 Hz, –OCH2CHN–), 2.20–
2.10 (1H, m, –CHMe2), 1.31 [9H, s, 3J(1H–
117/119Sn) = 98.0/102.6 Hz, –SntBu], 1.07 (3H, d, J = 6.8
Hz, –CHMe2), 0.87 (3H, d, J = 6.8 Hz, –CHMe2), 0.90
[3H, s, 3J(1H–117/119Sn) = 63.6/66.4 Hz, –SnMe]. 13C
NMR (CDCl3) ppm: 170.1 [J(13C–117/119Sn) = 8.3 Hz,
C10], 145.8 [J(13C–117/119Sn) = 537/562 Hz, C1], 138.4
[J(13C–117/119Sn) = 35.5 Hz], 132.5 [J(13C–117/119Sn) =
[J(13C–117/119Sn) = 648/678 Hz,
117/119Sn) = 575/602 Hz, Cphenyl], 138.5 [J(13C–117/119Sn) =
34.0 Hz], 135.4 132.9
[J(13C–117/119Sn) = 42.8 Hz],
[J(13C–117/119Sn) = 48.2 Hz], 130.4 [J(13C–117/119Sn) =
30.5 Hz], 129.4 128.6
[J(13C–117/119Sn) = 13.7 Hz],
C1],
144.7
[J(13C–
[J(13C–117/119Sn) = 13.5 Hz], 128.3 [J(13C–117/119Sn) =
56.0 Hz], 127.0 [J(13C–117/119Sn) = 40.0 Hz], 70.9 (C30),
70.8 [J(13C–117/119Sn) = 10.3 Hz, C40], 37.6 [J(13C–
117/119Sn) = 565/593 Hz, –SnC(CH3)3], 31.3 [–SnC(CH3)3],
30.5 (C50), 20.2 and 14.8 (C60). 117Sn NMR (CDCl3)
ppm: ꢀ161.4.
2.2.2.2. (R)-2-[(R,S)(S,R)-(2-iodo-tert-butyl-phenylstan-
nyl)-phenyl]-4-isopropyl-4,5-dihydro-oxazole (10). Mix-
ture of diastereoisomers 5.1/1, yellowish crystals, m.p.
198–201 ꢁC, 97%. [a]D = +77.8 (CHCl3, c = 1). IR cmꢀ1
(KBr): 3066, 2965, 2955, 2926, 2850, 1634, 1460, 1376,
t
1091, 944. MS (EI) m/z: 512 (M+ ꢀ Bu, 71), 442 (100),
386 (54), 308 (33), 222 (50). HRMS (EI): Calcd. for
C18H19N1O1120Sn1I1 511.9533. Found: 511.9548. Anal.
Calcd. for C22H28I1N1O1Sn1: C, 46.52; H, 4.97; N, 2.47;
I, 22.34. Found: C, 46.59; H, 4.97; N, 2.48; I, 20.78%.
Major diastereoisomer 10a: 1H NMR (CDCl3) ppm:
8.79–7.20 (9H, m, Harom.), 4.52 (1H, dd, J = 9.5 Hz,
J = 9.2 Hz, –OCH2CHN–), 4.39 (1H, dd, J = 8.8 Hz, J =
7.1 Hz, –OCH2CHN–), 4.17 (1H, ddd, J = 9.9 Hz, J =
7.1 Hz, J = 4.3 Hz, –OCH2CHN–), 1.52 [9H, s, 3J(1H–
117/119Sn) = 104.1/108.9 Hz, –SntBu], 1.47–1.40 (1H, m,
–CHMe2), 0.69 (3H, d, J = 6.7 Hz, –CHMe2), 0.25 (3H,
d, J = 6.7 Hz, –CHMe2). 13C NMR (CDCl3) ppm: 169.6
[J(13C–117/119Sn) = 8.1 Hz, C10], 148.8 [J(13C–117/119Sn) =
55.1 Hz],
129.5
[J(13C–117/119Sn) = 29.0 Hz],
129.1
[J(13C–117/119Sn) = 11.1 Hz], 126.7 [J(13C–117/119Sn) =
29.0 Hz], 70.3 (C30), 69.6 [J(13C–117/119Sn) = 10.7 Hz,
C40], 34.1 [J(13C–117/119Sn) = 573/600 Hz, –SnC(CH3)3],
30.7 [–SnC(CH3)3], 30.0 (C50), 19.4 and 14.6 (C60), 4.3
[J(13C–117/119Sn) = 460/481 Hz, –SnCH3]. 117Sn NMR
(CDCl3) ppm: ꢀ75.7. 15N NMR (CDCl3) ppm: ꢀ181.3
[J(15N–117/119Sn) = 116.3 Hz].
Minor diastereoisomer 11b: 1H NMR (CDCl3) ppm:
8.42–7.43 (4H, m,
Harom.), 4.62–4.57 (1H, m,
–OCH2CHN–), 4.39 (1H, t, J = 8.8 Hz, –OCH2CHN–),
4.08 (1H, ddd, J = 9.6 Hz, J = 4.3 Hz, J = 0.6 Hz,